Clinical trial · Observational
MRI in Renal Tumors
Advanced MRI in Renal Tumors.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Diagnostic imaging for renal masses of unknown nature using conventional imaging modalities such as 3 phase contrast-enhanced computed tomography (CT) is not always conclusive. After (partial) nephrectomy, 10-20 % of the resected tumors show benign histology which could not be identified on diagnostic imaging. With improved imaging techniques available, leading to improvements in characterisation of renal tumors, the number of unnecessary resections may be reduced. The objective of this study is to assess the ability to discriminate oncocytoma from RCC based on the ADC distribution parameters with addition of, tumor volume, and patient demographic characteristics.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Magnetic Resonance Imaging | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Renal tumor.
- description
- Patients \>18 years of age with histopathologically confirmed renal tumor diagnosis.
- interventionNames
- Device: Magnetic Resonance Imaging
Primary outcomes (1)
- measure
- Discriminating malignant from benign renal lesions using Apparent Diffusion Coefficient (ADC, a metric obtained by diffusion weighted MRI) value distribution analysis.
- timeFrame
- 45 months
Secondary outcomes (1)
- measure
- Additional value of tumor volume and patient characteristics to discriminate malignant from benign renal lesions.
- timeFrame
- 45 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Radiologic diagnosis of renal tumor based on previous ultrasonography, CT or MRI examinations. * Signed Institutional Review Board (IRB) approved informed consent form. * Being at least 18 years of age. * Histopathologically confirmed renal tumor diagnosis. Exclusion Criteria: * Relative contra indications for MRI (metal device/foreign bodies, claustrophobia); * Active renal or perirenal infection; * Minor and/or incapacitated adult.
References
Publications (0)
Data not yet available